Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance.
Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Account summary
Search detail for: Pharmaceutical Research and Manufacturers of America Corporation
Registration year: 2023
Registration type: Client
Address: 950 F Street NW, Suite 300, Washington, DC, 20004 US / 202-835-3547
Lobbyist information Amount
Kevin Bourque $14,086.40
Employed Terminated Details about your lobbyist or lobbyist entity's efforts
01/01/2023 Marketing, privacy, price controls, and business practices, among other matters related to pharmaceuticals and health care as may be introduced.
 
Leslie Wood $18,740.39
Employed Terminated Details about your lobbyist or lobbyist entity's efforts
01/01/2023 Issues and legislation related to prescription medicines including drug and sharps take back, prescription drug abuse, health care reform, and cost containment.
 
Rachel Cottle Latham $11,322.12
Employed Terminated Details about your lobbyist or lobbyist entity's efforts
03/23/2023 Issues and legislation related to prescription medicines including drug and sharps take back, prescription drug abuse, health care reform, and cost containment.
 
Total salaries paid:      $44,148.91
Lobbyist Entity information Amount
Bay State Strategies Group, LLC $205,003.00
Employed Terminated
01/01/2023
 
Commonwealth Counsel, LLC $54,000.00
Employed Terminated
03/01/2023
 
Finneran Global Strategies $72,500.00
Employed Terminated
01/01/2023
 
Total salaries paid:      $331,503.00
Expenditures Amount
Operating Expenses $817,847.17
Meal, Entertainment, and Travel Expenses $14,201.79
Total expenses:      $832,048.96
Registration details

Disclosure Report details


Close this page